Attached files
| file | filename |
|---|---|
| EX-10.18 - EX-10.18 - G1 Therapeutics, Inc. | gthx-ex1018_546.pdf |
| EX-32.2 - EX-32.2 - G1 Therapeutics, Inc. | gthx-ex322_8.htm |
| EX-32.1 - EX-32.1 - G1 Therapeutics, Inc. | gthx-ex321_9.htm |
| EX-31.2 - EX-31.2 - G1 Therapeutics, Inc. | gthx-ex312_10.htm |
| EX-31.1 - EX-31.1 - G1 Therapeutics, Inc. | gthx-ex311_11.htm |
| EX-10.18 - EX-10.18 - G1 Therapeutics, Inc. | gthx-ex1018_546.htm |
| 10-K - 10-K - G1 Therapeutics, Inc. | gthx-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S‑8 (No. 333-218468) of G1 Therapeutics, Inc. of our report dated February 21, 2018 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
February 21, 2018